Curcumin alleviates cisplatin-induced learning and memory impairments

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Cisplatin is a widely used chemotherapy agent with known neurotoxic side effects, including cognitive impairment.
• The exact mechanisms underlying cisplatin-induced cognitive deficits are not fully understood but involve oxidative stress and cholinergic dysfunction.
• Curcumin, a natural compound, possesses antioxidant and anti-inflammatory properties that may offer neuroprotection.

Purpose of the Study:

• To investigate the protective effects of curcumin against cisplatin-induced cognitive impairment in a rat model.
• To elucidate the potential mechanisms by which curcumin exerts its neuroprotective effects.

Main Methods:

• Rats were administered cisplatin and/or curcumin for five weeks.
• Spatial learning and memory were assessed using the Morris water maze test.
• Hippocampal and plasma levels of acetylcholinesterase (AChE), superoxide dismutase (SOD), and malondialdehyde (MDA) were measured.

Main Results:

• Cisplatin treatment resulted in significant learning and memory deficits, increased MDA levels, and decreased SOD and AChE activities.
• Curcumin administration ameliorated cisplatin-induced cognitive impairments.
• Curcumin treatment significantly reduced MDA levels and increased SOD and AChE activities in cisplatin-treated rats.

Conclusions:

• Curcumin demonstrates significant neuroprotective effects against cisplatin-induced cognitive impairment in rats.
• These protective effects may be attributed to curcumin's ability to restore cholinergic function and enhance antioxidant status.
• Curcumin represents a potential therapeutic agent to mitigate chemotherapy-induced cognitive side effects.